Skandinaviska Enskilda Banken (SEB)’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-31,373
| Closed | -$183K | – | 908 |
|
|
2025
Q1 | $183K | Buy |
+31,373
| New | +$165K | ﹤0.01% | 747 |
|
|
2024
Q1 | – | Sell |
-15,200
| Closed | -$327K | – | 967 |
|
|
2023
Q4 | $327K | Buy |
15,200
+10,900
| +253% | +$194K | ﹤0.01% | 804 |
|
|
2023
Q3 | $83K | Sell |
4,300
-800
| -16% | -$17.1K | ﹤0.01% | 883 |
|
|
2023
Q2 | $130K | Buy |
5,100
+1,600
| +46% | +$46.2K | ﹤0.01% | 884 |
|
|
2023
Q1 | $127K | Buy |
+3,500
| New | +$123K | ﹤0.01% | 852 |
|
|
2022
Q3 | – | Sell |
-10,015
| Closed | -$439K | – | 1045 |
|
|
2022
Q2 | $439K | Buy |
10,015
+4,155
| +71% | +$228K | ﹤0.01% | 830 |
|
|
2022
Q1 | $424K | Sell |
5,860
-2,909
| -33% | -$210K | ﹤0.01% | 851 |
|
|
2021
Q4 | $720K | Hold |
8,769
| – | – | ﹤0.01% | 811 |
|
|
2021
Q3 | $1.02M | Buy |
8,769
+1,368
| +18% | +$179K | 0.01% | 781 |
|
|
2021
Q2 | $1.23M | Buy |
7,401
+208
| +3% | +$32.5K | 0.01% | 779 |
|
|
2021
Q1 | $1M | Buy |
7,193
+688
| +11% | +$112K | 0.01% | 830 |
|
|
2020
Q4 | $1.13M | Buy |
6,505
+975
| +18% | +$158K | 0.01% | 787 |
|
|
2020
Q3 | $770K | Buy |
5,530
+5,405
| +4,324% | +$722K | 0.01% | 779 |
|
|
2020
Q2 | $15K | Buy |
+125
| New | +$14.8K | ﹤0.01% | 1028 |
|
Other funds holding NVRO
Skandinaviska Enskilda Banken (SEB)'s NVRO Position: Q2 2025 in Review
Skandinaviska Enskilda Banken (SEB) sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 31,373 shares — an estimated $183K sold.
Skandinaviska Enskilda Banken (SEB) first reported a position in NVRO in Q2 2020 and held it in 14 quarters. The position peaked at $1.23M in Q2 2021. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- Skandinaviska Enskilda Banken (SEB) reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- Skandinaviska Enskilda Banken (SEB) sold 31,373 NEVRO CORP. shares in Q2 2025, an estimated $183K.
- Skandinaviska Enskilda Banken (SEB) first reported a position in NEVRO CORP. in Q2 2020 and held it in 14 quarters.
- Skandinaviska Enskilda Banken (SEB)'s NEVRO CORP. position peaked at $1.23M in Q2 2021.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2025, filed 13 Aug 2025.